Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intensification and stem cell transplantation in adult acute lymphoblastic leukemia
ISRCTN77441569Phase 2Completed
- Sponsor
- HOVON
- Start
- Apr 1999
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of prednisone, vincristine, daunorubicin, asparaginase escherichia coli, methotrexate and 3 more in acute lymphoblastic leukemia (ALL) (3 arms), sponsored by HOVON. Primary endpoint: Response after each course of chemotherapy and date of complete remission. Started Apr 1999; status: completed.
02
Drugs
prednisonevincristinedaunorubicinasparaginase escherichia colimethotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on ISRCTN77441569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN77441569.